Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.

US FDA Approves Fortress Bio and Zydus' Treatment for a Rare Pediatric Disease The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for ...

Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...

While most may feel distress when identified as high risk for certain medical conditions, Thng Kay Tiong felt relief when he ...

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim ...

As the NHS shifts care from hospitals to communities, this long read explores why research and innovation remain heavily ...

Future advances in honey bee research at NC State is made possible by support of the NC State Beekeepers Association (NCSBA).